On June 4, Zoetis rose 5.07% in regular trading, trading at $81.48/share, with trading volume of $173 million.
Within the Pharmacy sector where Zoetis belongs, the overall sector performed strongly. Among individual stocks, Novo-Nordisk up 5.25%, Eli Lilly up 5.01%, Merck up 3.48%, Johnson & Johnson up 1.79%, Pfizer up 1.76%.
Zoetis Inc. is a global leader in animal health, focused on the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products, and services across livestock and companion animal species.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments